"Benzazepines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds with BENZENE fused to AZEPINES.
| Descriptor ID |
D001552
|
| MeSH Number(s) |
D03.633.100.079
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzazepines".
Below are MeSH descriptors whose meaning is more specific than "Benzazepines".
This graph shows the total number of publications written about "Benzazepines" by people in this website by year, and whether "Benzazepines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Benzazepines" by people in Profiles.
-
Vidic A, Shuster JE, Goff ZD, Godishala A, Joseph SM, Chibnall JT, Hauptman PJ. Vasopressin antagonism for decompensated right-sided heart failure. Int J Cardiol. 2019 Jan 01; 274:245-247.
-
Ruzieh M, Sirianni N, Ammari Z, Dasa O, Alhazmi L, Karabin B, Grubb B. Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience. Pacing Clin Electrophysiol. 2017 Nov; 40(11):1242-1245.
-
Lipshultz SE, Barach PR, Wilkinson JD. Does Lowering Heart Rate Improve Outcomes in Children With Dilated?Cardiomyopathy and Chronic?Heart Failure? J Am Coll Cardiol. 2017 09 05; 70(10):1273-1275.
-
Kim DH, Chien FJ, Eisen HJ. Pharmacologic Management for Heart Failure and Emerging Therapies. Curr Cardiol Rep. 2017 08 24; 19(10):94.
-
Konstam MA, Kiernan M, Chandler A, Dhingra R, Mody FV, Eisen H, Haught WH, Wagoner L, Gupta D, Patten R, Gordon P, Korr K, Fileccia R, Pressler SJ, Gregory D, Wedge P, Dowling D, Romeling M, Konstam JM, Massaro JM, Udelson JE. Short-Term Effects of Tolvaptan in Patients?With Acute Heart Failure and?Volume Overload. J Am Coll Cardiol. 2017 Mar 21; 69(11):1409-1419.
-
Kosiuk J, Lindemann F, Hindricks G, Bollmann A. Need for further studies on ivabradine in patients with persistent atrial fibrillation. Int J Cardiol. 2016 Nov 15; 223:915-916.
-
Kosiuk J, Oebel S, John S, Hilbert S, Hindricks G, Bollmann A. Ivabradine for rate control in atrial fibrillation. Int J Cardiol. 2015 Jan 20; 179:27-8.
-
Debeb BG, Cohen EN, Boley K, Freiter EM, Li L, Robertson FM, Reuben JM, Cristofanilli M, Buchholz TA, Woodward WA. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Res Treat. 2012 Jul; 134(2):495-510.
-
Gassanov N, Semmo N, Semmo M, Nia AM, Fuhr U, Er F. Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Eur J Clin Pharmacol. 2011 Apr; 67(4):333-346.
-
Whellan DJ. Introduction: Vasopressin therapy. Heart Fail Rev. 2009 Jun; 14(2):57-8.